CN111420013A - A Chinese medicinal composition for treating cholecystitis, cholangitis and cholelithiasis - Google Patents
A Chinese medicinal composition for treating cholecystitis, cholangitis and cholelithiasis Download PDFInfo
- Publication number
- CN111420013A CN111420013A CN202010416546.0A CN202010416546A CN111420013A CN 111420013 A CN111420013 A CN 111420013A CN 202010416546 A CN202010416546 A CN 202010416546A CN 111420013 A CN111420013 A CN 111420013A
- Authority
- CN
- China
- Prior art keywords
- parts
- cholangitis
- weight
- cholecystitis
- treating cholecystitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 26
- 208000003167 cholangitis Diseases 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title claims description 13
- 201000001883 cholelithiasis Diseases 0.000 title description 6
- 239000003814 drug Substances 0.000 claims abstract description 27
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 8
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 7
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 6
- 241001183967 Isodon Species 0.000 claims abstract description 6
- 244000272459 Silybum marianum Species 0.000 claims abstract description 6
- 235000010841 Silybum marianum Nutrition 0.000 claims abstract description 6
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 6
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 235000013976 turmeric Nutrition 0.000 claims abstract description 6
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 5
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 5
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 5
- 235000006793 Artemisia stelleriana Nutrition 0.000 claims abstract description 5
- 244000252230 Artemisia stelleriana Species 0.000 claims abstract description 5
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 5
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 5
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 5
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 5
- 241000175995 Dichondra Species 0.000 claims abstract description 5
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 5
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 5
- 241000195974 Selaginella Species 0.000 claims abstract description 5
- 241000317854 Uncinata Species 0.000 claims abstract description 5
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 5
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 abstract description 5
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 208000031975 Yang Deficiency Diseases 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 210000000232 gallbladder Anatomy 0.000 description 21
- 210000000941 bile Anatomy 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 16
- 230000000694 effects Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 7
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 210000003445 biliary tract Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 201000009361 ascariasis Diseases 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 235000012754 curcumin Nutrition 0.000 description 3
- 229940109262 curcumin Drugs 0.000 description 3
- 239000004148 curcumin Substances 0.000 description 3
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 241000244186 Ascaris Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000245665 Taraxacum Species 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 210000001096 cystic duct Anatomy 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000027534 Emotional disease Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000025599 Heat Stress disease Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000265736 Nelumbo pentapetala Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010071301 Perihepatitis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- NNBFNNNWANBMTI-UHFFFAOYSA-M brilliant green Chemical compound OS([O-])(=O)=O.C1=CC(N(CC)CC)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](CC)CC)C=C1 NNBFNNNWANBMTI-UHFFFAOYSA-M 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 238000002192 cholecystectomy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229960002997 dehydrocholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating cholecystitis, cholangitis and biliary calculus, which is prepared from the following raw material medicines in parts by weight: 2-4 parts of goldthread root; 4-8 parts of turmeric; 6-12 parts by weight of silybum marianum, fennel, dark plum and oriental wormwood; 9-18 parts of artemisia stelleriana; 15-30 parts of creeping dichondra, dandelion, linearstripe rabdosia herb and uncinata spikemoss herb. It is contraindicated for patients with yang deficiency, external cold, and spleen and stomach deficiency.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating cholecystitis, cholangitis and biliary calculus.
Background
Sudden obstruction or incarceration of the cystic duct of the gallbladder is a common cause of acute cholecystitis, which can also be caused by cystic duct torsion, stenosis, and obstruction of biliary ascariasis or biliary tumor. At present, no specific medicine for treating cholecystitis, cholangitis and biliary calculus exists. Western medicine adopts spasmolysis, analgesia and antibacterial therapy, and 50% of magnesium copaiate, dehydrocholic acid tablet or cholecystectomy is orally taken. Western medicines can only relieve the state of an illness, cannot radically cure the operation, and are high in cost and high in risk.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provides the traditional Chinese medicine composition for treating cholecystitis, cholangitis and biliary calculi, which can effectively improve or even eliminate clinical symptoms of patients and has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Cholecystitis belongs to the category of diseases such as shaoyang disease, gallbladder excess heat, gallbladder distention and hypochondriac pain. Ancient people thought that the gallbladder is attached to the liver, and the gallbladder is exterior-interior to the liver, and the liver-gallbladder is located in the hypochondrium, which is called Ling Shu-distending Lun: for gallbladder distention, hypochondriac pain and distension, bitter taste in mouth and frequent sighing. The expression "syndrome treatment tonifying" means: the liver is the most yin, prefers to be stripped and dislocated, the gallbladder is not cleared, and prefers to be developed and dislocated, so the pain is more serious when the liver is not depressed, the qi is not released, and the fire is not released, so the liver is not healed and the pain is cured. "this fully indicates that the onset of cholecystitis is caused by failure to reach the body. The gallbladder is rigid and straight, mainly breaks, emotional disorder, cold and warm discomfort, improper diet, greasy and fat food overeating, or insect accumulation and the like can cause qi and blood stagnation, diseases of the gallbladder can cause damp-heat fatigue and middle-jiao accumulation, the middle-jiao clearing and descending of the gallbladder are affected, stagnation of the gallbladder qi is obstructed and pain is caused, the bile reversely overflows the skin to become yellow, and the heat accumulation is not dispersed to form pus. When the secretion of liver and gallbladder and the movement function of gallbladder and sphincter are affected, the bile is retained and may be infected, and the metabolism function of bile is changed to form calculus. The pathological factors are damp-heat, qi stagnation, blood stasis and excessive toxicity. Therefore, it has the effects of clearing away heat and toxic materials, removing blood stasis, promoting circulation of qi, protecting liver, promoting function of gallbladder, and removing dampness and swelling. The organism of the human body is regulated on the whole, thereby achieving the purpose of thorough healing.
1. Based on the theory, the invention provides a traditional Chinese medicine for treating cholecystitis, cholangitis and biliary calculus, which is prepared from the following raw material medicines in parts by weight: 2-4 parts of goldthread root; 4-8 parts of turmeric; 6-12 parts by weight of silybum marianum, fennel, dark plum and oriental wormwood; 9-18 parts of artemisia stelleriana; 15-30 parts of creeping dichondra, dandelion, linearstripe rabdosia herb and uncinata spikemoss herb.
2. In a preferred embodiment, the traditional Chinese medicine composition for treating cholecystitis, cholangitis and biliary calculus comprises the following raw material medicines in parts by weight: 4 parts of goldthread root; 8 parts of turmeric; silybum marianum, fennel, dark plum fruit and oriental wormwood 12 parts by weight; 18 parts of artemisia stelleriana; 30 parts of creeping dichondra, dandelion, rabdosia lophanthide and uncinata spikemoss herb.
Wherein silybum marianum is bitter and cool. Clearing away heat and toxic material, protecting liver, promoting function of gallbladder, protecting brain, and resisting X-ray. Can be used for treating cholelithiasis; cholangitis. Has good curative effect on liver and gall diseases such as acute or chronic hepatitis, liver cirrhosis, fatty liver, metabolic poisoning liver injury, cholelithiasis, cholangitis, perihepatitis of the liver and the like.
Herba talinae: pungent and mild in flavor. Clear heat and promote diuresis, remove toxicity and relieve swelling. Can be used for treating hepatitis, cholecystitis, nephritis, edema, urinary system infection, urinary calculus, tonsillitis, and traumatic injury.
And (3) yellow lotus: bitter and cold. It enters heart, spleen, stomach, liver, gallbladder and large intestine meridians. Clear heat and dry dampness, purge fire and remove toxicity. Berberine contained in Coptidis rhizoma has bile benefiting effect, and can increase bile formation and dilute bile, and has good effect for patients with chronic cholecystitis by oral administration.
Dandelion: bitter, sweet and cold. It enters liver and stomach meridians. Clearing away heat and toxic material, dispersing swelling and dissipating stagnation, inducing diuresis and treating stranguria. Dandelion has the function of benefiting gallbladder, Dandelion liquid can contract gallbladder and relax sphincter Oddi, thus being beneficial to discharge bile into intestine and being clinically effective to chronic cholecystospasm and lithiasis.
Artemisia princeps Pampanini: pungent and warm. Dry dampness and kill parasites. Can be used for treating cholecystitis, ascaris, and enterobiasis.
Fragrant horns: is bitter in taste; pungent taste; and (6) cooling. Entering the lung; the large intestine; the liver meridian. Clearing away heat and toxic materials; relieving cough and pain. Can be used for treating hepatitis; cholecystitis, and the like.
Rabdosia lophanthide: is bitter in taste; is cold in nature. Liver diseases entering; a bladder; the large intestine channel. Clearing away heat and toxic materials; removing dampness and eliminating jaundice; dispel stasis and relieve swelling. Used for treating damp-heat jaundice; cholecystitis is known as cholecystitis.
B, emerald green grass: sweet, bland and cool. Clear heat and promote diuresis, stop bleeding, and relieve cough. It is indicated for cholecystitis.
Herba artemisiae scopariae: bitter, pungent and slightly cold. It is entered into spleen, stomach, liver and gallbladder meridians. Clear damp-heat and alleviate jaundice. Can be used for treating jaundice, oliguria, eczema, and pruritus; infectious icteric hepatitis. Herba Artemisiae Scopariae has obvious choleretic effect, and can increase bile secretion and discharge of solid, cholic acid and bilirubin in bile.
Turmeric: pungent, bitter and warm. It enters spleen and liver meridians. Break blood and move qi, dredge meridians to alleviate pain. The turmeric extract, curcumin, volatile oil, turmerone, shogaol, borneol, sesquiterpene alcohol and the like all have the beneficial effects of benefiting bile, increasing the generation and secretion of bile, recovering bile components to be normal and promoting gallbladder contraction, and the effect of curcumin is the strongest. Curcumin or its sodium salt has choleretic effect, and can reduce solid content to increase bile secretion, but in terms of total absolute value, bile salt, bilirubin, and cholesterol secretion increase, and fatty acid component remains constant. Can be used for treating cholelithiasis. The 50% decoction of Curcuma rhizome can promote appetite.
Dark plum: sour, astringent and neutral. It enters liver, spleen, lung and large intestine meridians. Astringe lung, astringe intestine, promote fluid production and relieve ascaris. Can be used for treating abdominal pain due to ascariasis, emesis, and ascariasis of biliary tract. The dark plum soup has the effects of promoting contraction and cholagogue of gallbladder, facilitating drainage of bile in biliary tract, reducing and preventing infection of biliary tract, and reducing biliary calculus formed by ascarid eggs left in biliary tract, so as to reduce occurrence of cholelithiasis, increase secretion of bile, and make bile tend to be acidic.
The Chinese medicine is prepared from traditional Chinese herbal medicines, and is a Chinese medicine for effectively treating cholecystitis, cholangitis and biliary calculus by orderly matching certain natural extracts with determined components and clear effects according to a plurality of principles of traditional Chinese medicine treatment based on syndrome differentiation and modern medicine.
The invention can be used throughout the whole treatment process of cholecystitis, cholangitis and biliary calculus, treats both symptoms and root causes, is not easy to relapse, is safe and reliable, has no obvious toxic or side effect, is convenient for patients to insist on taking for a long time, has no adverse reaction for the patients after taking the medicine for many years, and tracks the blood to check normally.
The traditional Chinese medicine composition has the advantages of easily available raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises for medicine production and quality control; the product has low price and is easy to be accepted by patients.
The traditional Chinese medicine composition has remarkable effect of treating cholecystitis, cholangitis and biliary calculus, and clinical experiment results show that the prescription is used for treatment, one dose of the traditional Chinese medicine composition is taken every day, 100 ml of water is decocted, the traditional Chinese medicine composition is divided into two parts, the medicine composition is taken one part in the morning and evening, one month is taken as a treatment course, generally one treatment course is effective, three treatment courses can be obviously improved, and the functions of six treatment courses are basically cured. The cure rate is 78 percent after 6 treatment courses, the significant efficiency is 88 percent, and the total effective rate is 100 percent.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating cholecystitis, cholangitis and biliary calculus, wherein the oral preparation comprises oral liquid, tablets, capsules, pills and the like, preferably the dosage forms are tablets and capsules, and one dose is taken in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.
Claims (4)
1. The traditional Chinese medicine for treating cholecystitis, cholangitis and biliary calculus is characterized by comprising the following raw material medicines in parts by weight: 2-4 parts of goldthread root; 4-8 parts of turmeric; 6-12 parts by weight of silybum marianum, fennel, dark plum and oriental wormwood; 9-18 parts of artemisia stelleriana; 15-30 parts of creeping dichondra, dandelion, linearstripe rabdosia herb and uncinata spikemoss herb.
2. The traditional Chinese medicine for treating cholecystitis, cholangitis and biliary calculus according to claim 1, which is prepared from the following raw materials in parts by weight: 4 parts of goldthread root; 8 parts of turmeric; silybum marianum, fennel, dark plum fruit and oriental wormwood 12 parts by weight; 18 parts of artemisia stelleriana; 30 parts of creeping dichondra, dandelion, rabdosia lophanthide and uncinata spikemoss herb.
3. An oral preparation for treating cholecystitis, cholangitis and biliary calculus, which is prepared from the Chinese medicinal composition of any one of claims 1 or 2.
4. The oral preparation for treating cholecystitis, cholangitis and biliary calculus according to claim 3, which comprises oral liquid, tablets, capsules and pills, preferably oral liquid and tablets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010416546.0A CN111420013A (en) | 2020-05-18 | 2020-05-18 | A Chinese medicinal composition for treating cholecystitis, cholangitis and cholelithiasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010416546.0A CN111420013A (en) | 2020-05-18 | 2020-05-18 | A Chinese medicinal composition for treating cholecystitis, cholangitis and cholelithiasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111420013A true CN111420013A (en) | 2020-07-17 |
Family
ID=71551017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010416546.0A Pending CN111420013A (en) | 2020-05-18 | 2020-05-18 | A Chinese medicinal composition for treating cholecystitis, cholangitis and cholelithiasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111420013A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111714601A (en) * | 2020-08-09 | 2020-09-29 | 仲崇允 | A Chinese medicinal composition for treating fungal infection |
-
2020
- 2020-05-18 CN CN202010416546.0A patent/CN111420013A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111714601A (en) * | 2020-08-09 | 2020-09-29 | 仲崇允 | A Chinese medicinal composition for treating fungal infection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106334077A (en) | Traditional Chinese medicine prescription for treating allergic rhinitis | |
| CN111420013A (en) | A Chinese medicinal composition for treating cholecystitis, cholangitis and cholelithiasis | |
| CN103751547B (en) | Chinese medicine composition of a kind of blood fat reducing and preparation method thereof | |
| CN100579544C (en) | Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof | |
| CN113181258A (en) | A Chinese medicinal composition for treating menoxenia, dysmenorrhea, and amenorrhea | |
| CN114028507A (en) | Preparation method of traditional Chinese medicine for treating lumbago | |
| CN113413431A (en) | Traditional Chinese medicine formula for preventing and treating hypertension | |
| CN108619427B (en) | Pain-relieving and acid-reducing herb tea for preventing and treating gouty arthritis | |
| CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
| CN104800772A (en) | Traditional Chinese medicine composition for treating vital-energy-depression type coronary heart disease and application of traditional Chinese medicine composition | |
| CN109512965A (en) | A kind of heat-clearing TONGBI PIAN and preparation method thereof | |
| CN103585517A (en) | Drug composition for treating hepatitis and cholecystitis and preparation method thereof | |
| CN115120690B (en) | Traditional Chinese medicine composition for treating precocious puberty and application thereof | |
| CN105920229A (en) | Traditional Chinese medicine composition for treating acute ankle sprain | |
| CN105999106A (en) | Traditional Chinese medicine composition for treating acute and chronic cholecystitis | |
| CN105663850A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN111700951A (en) | Chinese medicinal composition for treating abdominal mass | |
| CN116688056A (en) | A Chinese medicinal composition for oral administration for treating hemorrhoid, herpes zoster, furuncle, sore, and fistula, and its preparation method | |
| CN111714601A (en) | A Chinese medicinal composition for treating fungal infection | |
| CN105125978A (en) | Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof | |
| CN106309926A (en) | Composition prepared from bee products and medical and edible dual-purpose food and used for treating gastritis and gastric ulcer | |
| CN114028486A (en) | Propolis stomach invigorating pill | |
| CN112891425A (en) | Traditional Chinese medicine composition for ascending the clear, descending the turbid and benefiting the spleen | |
| CN110694038A (en) | External traditional Chinese medicine composition for treating cholecystitis | |
| CN113398225A (en) | Traditional Chinese medicine for alcoholic hepatic fibrosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200717 |